Comparing Chronic Disease Patterns between Germany and the US

Prof. Dr. Norbert Klusen; Dr. Frank Verheyen

doi:10.5771/9783845239972

Summary

Zwischen den Gesundheitssystemen in den USA und in Deutschland existieren große Unterschiede. Dabei bemühen sich beide Länder, die Qualität der Patientenversorgung weiter zu verbessern und gleichzeitig die steigenden Kosten in den Griff zu bekommen. Wie erfolgreich sind diese Systeme? Worin unterscheiden sich Qualität und Kosten? Was können wir voneinander lernen? Für die chronischen Erkrankungen Diabetes, Bluthochdruck und Fettstoffwechselstörungen erlaubt die vorliegende Untersuchung ? ausgehend von Hunderttausenden an Abrechnungsdaten diesseits und jenseits des Atlantiks ? erstmals einen Vergleich der Behandlungsmuster und -ergebnisse.

Wie sich zeigt, sind die Behandlungskosten in den USA in allen Bereichen der Versorgung erheblich höher. In den USA wird teilweise konsequenter medikamentös behandelt. Zugleich tritt Diabetes in den USA bereits häufiger in jungen Altersgruppen auf, möglicherweise ein Ausblick auf eine zukünftige Entwicklung hierzulande, der es mit allen Möglichkeiten der Prävention zu begegnen gälte.

Die Autoren sind international renommierte Professoren und Wissenschaftler mit langjähriger Erfahrung auf dem Gebiet der Versorgungsforschung.

Search publication

Bibliographic data

Copyright year: 2012
ISBN-Print: 978-3-8329-7477-0
ISBN-Online: 978-3-8452-3997-2
Publisher: Nomos, Baden-Baden
Series: Beiträge zum Gesundheitsmanagement
Volume: 35
Language: English
Pages: 180
Product type: Edited Book

Titelei/Inhaltsverzeichnis No access Pages 1 - 12
1. Einleitung No access
2. Methode No access
3. Feststellungen No access
4. Folgerungen und Empfehlungen No access
5. Zusammenfassung No access
1. Introduction No access
2. Method No access
3. Results No access
4. Conclusions and Recommendations No access
5. Summary No access
1. Techniker Krankenkasse – RAND Collaboration and Initial Study No access
2. Objectives and Research Questions for the Present Study No access
3. Rationale No access
4. Summary of Key Findings No access
5. Organization of the Remainder of the Report No access
1. Diabetes No access
2. Hypertension No access
3. Lipid Disorders No access
4. Comorbidities No access
5. Metabolic Syndrome No access
6. Summary No access
1. Data Sources No access
2. Sample Selection No access
3. Data Transformations for the Identifications of Comorbidities No access
4. Study Samples No access
5. 1. Treated Diabetes No access
  2. Treated Hypertension No access
  3. Treated Lipid Disorders No access
6. Methods for Comparative Assessment No access
1. The Sample of Patients with Treated Diabetes in Germany and the US No access
2. Prevalence of Comorbidities among Treated Diabetics No access
3. Treatment of Comorbidities among Treated Diabetics No access
4. 1. Outpatient Care No access
  2. Inpatient Care No access
5. 1. Total Medical Spending No access
  2. Outpatient Spending No access
  3. Inpatient Spending No access
  4. Prescription Drug Spending No access
1. The Sample of Patients with Treated Hypertension in Germany and the US No access
2. Prevalence of Comorbidities among Patients with Treated Hypertension No access
3. Treatment of Comorbidities among Treated Hypertensives No access
4. 1. Outpatient Care No access
  2. Inpatient Care No access
5. 1. Total Medical Spending No access
  2. Outpatient Spending No access
  3. Inpatient Spending No access
  4. Prescription Drug Spending No access
1. The Sample of Patients with Treated Lipid Disorders in Germany and the US No access
2. Prevalence of Comorbidities among Patients with Treated Lipid Disorders No access
3. Treatment of Comorbidities among Patients with a Treated Lipid Disorder No access
4. 1. Outpatient Care No access
  2. Inpatient Care No access
5. 1. Total Medical Spending No access
  2. Outpatient Spending No access
  3. Inpatient Spending No access
  4. Prescription Drug Spending No access
1. 1. 1. Onset of Hypertension Among Patients with Treated Diabetes No access
    2. Onset of Lipid Disorder Among Patients with Treated Diabetes No access
  2. 1. Onset of Diabetes Among Patients with Treated Hypertension No access
    2. Onset of Lipid Disorder Among Patients with Treated Hypertension No access
  3. 1. Onset of Diabetes Among Patients with Treated Lipid Disorders No access
    2. Onset of Hypertension Among Patients with Treated Lipid Disorders No access
2. 1. 1. Onset of Cardiac Disease No access
    2. Onset of Central Nervous System Disease No access
    3. Onset of Ocular Disease No access
    4. Peripheral Neuropathy No access
    5. Onset of Peripheral Vascular Disease No access
    6. Renal Disease No access
  2. 1. Onset of Cardiac Disease No access
    2. Onset of Central Nervous System Disease No access
    3. Onset of Ocular Disease No access
    4. Onset of Peripheral Neuropathy No access
    5. Onset of Peripheral Vascular Disease No access
    6. Onset of Renal Disease No access
  3. 1. Onset of Cardiac Disease No access
    2. Onset of Central Nervous System Disease No access
    3. Onset of Ocular Disease No access
    4. Onset of Peripheral Neuropathy No access
    5. Onset of Peripheral Vascular Disease No access
    6. Onset of Renal Disease No access
1. 1. Comorbidities and their Pharmacological Treatment No access
  2. Health care use and spending No access
2. 1. Comorbidities No access
  2. Complications No access
3. 1. Sample selection No access
  2. Data coding and patient classification No access
  3. Modeling issues No access
4. References No access
1. 1. Prevalence of Comorbidities among Patients with Treated Diabetes No access
  2. Treatment of Comorbidities Among Patients with Treated Diabetes No access
  3. Medical Care Utilization among Patients with Treated Diabetics No access
  4. Medical Care Spending Among Patients with Treated Diabetes No access
2. 1. Prevalence of Comorbidities among Patients with Treated Hypertension No access
  2. Treatment of Comorbidities Among Patients with Treated Diabetes No access
  3. Medical Care Utilization among Patients with Treated Hypertension No access
  4. Medical Care Spending Among Patients with Treated Hypertension No access
3. 1. Prevalence of Comorbidities among Patients with a Treated Lipid Disorder No access
  2. Treatment of Comorbidities Among Patients with a Treated Lipid Disorder No access
  3. Medical Care Utilization among Patients with a Treated Lipid Disorder No access
  4. Medical Care Spending Among Patients with a Treated Lipid Disorder No access
4. Appendix with Supporting Material for Chapter 7 (Disease Transitions) No access
1. Einleitung No access
2. Methodik No access
3. 1. Diabetes mellitus No access
  2. Hypertonie No access
  3. Dyslipidämie No access
4. Diskussion und Ausblick No access
5. Literatur No access
Authors No access Pages 177 - 180